Equity Insider News Commentary - The global market for artificial intelligence in drug discovery is projected to grow from $5.09 billion in ...
Company advances manufacturing scale-up, regulatory testing and preclinical work supporting its planned FDA 510(k) submission in the first quarter of 2027.Multiple scaled-up batches of CXU™ material ...
Solventum, whose MedSurg business includes negative pressure wound therapy and advanced dressings, reported second quarter 2026 sales of $2.2 billion, with organic growth of 9.5%. Advanced Wound Care ...
Edwards Lifesciences (NYSE: EW) today announced that it will host an investor event in conjunction with the TCT annual scientific symposium in San Diego on Monday, Nov. 2, from 5:00 to 6:00 PM Pacific ...
Five UC Santa Barbara researchers will collaborate across three NSF Quantum Leap Challenge Institutes to advance quantum computing, sensing, and hardware.
Nutriband CEO Gareth Sheridan Congratulates Shareholders on Five-Year Nasdaq Listing Anniversary. CEO letter reflects on five years of milestones since the Company's October 1, 20 ...
Achieve Life Sciences, Inc. (Achieve or the Company) (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a ...
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Avantor (NYSE:AVTR) and the best and worst ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results